Ibm Retirement Fund Bio Techne Corp Transaction History

Ibm Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$322.67 - $449.65 $196,828 - $274,286	-610 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$353.85 - $487.79 $11,677 - $16,097	-33 Reduced 5.13%	610 $264,000
Q4 2021 Jan 19, 2022	SELL	$456.15 - $525.06 $203,442 - $234,176	-446 Reduced 40.96%	643 $333,000
Q2 2021 Jul 12, 2021	SELL	$387.35 - $450.26 $79,019 - $91,853	-204 Reduced 15.78%	1,089 $490,000
Q1 2021 Apr 22, 2021	SELL	$314.62 - $411.0 $34,293 - $44,799	-109 Reduced 7.77%	1,293 $494,000
Q4 2020 Jan 25, 2021	BUY	$246.9 - $321.87 $41,479 - $54,074	168 Added 13.61%	1,402 $445,000
Q3 2020 Oct 16, 2020	BUY	$232.22 - $282.96 $80,580 - $98,187	347 Added 39.12%	1,234 $306,000
Q2 2020 Jul 08, 2020	BUY	$185.43 - $279.56 $164,476 - $247,969	887 New	887 $234,000

596

152M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.88B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.